March 20, 2020 / By Mike Hixenbaugh Dr. Arturo Casadevall was working from home in Baltimore on Thursday when his phone started to buzz with messages from colleagues. The commissioner of the Food and Drug Administration had just announced during a White House press briefing that the agency was investigating the possibility of using blood plasma donated …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone